Letters Cancer drugs, survival, and ethics
Distilling ethics, compassion, science and the art of medicineBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6510 (Published 05 December 2016) Cite this as: BMJ 2016;355:i6510
View Full Text
- Leong Ng, consultant physician-specialist medical oncologist and family practitioner,
- Yolande Lucire, consultant forensic psychiatrist and specialist in pharmacogenomics
- Edgecliff, NSW 2027, Australia
We agree with Wise.1 Clinicians, patients, their families, and regulators must all understand the difference between treatments that are potentially curative and the majority that are palliative. Based on risks, benefits, and possibilities, the patient gives informed consent for an intervention.
In Sydney, Australia, oncologists in a reputable hospital have arranged to have a senior colleague charged with “underdosing,” creating the impression …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.